| dc.date.accessioned | 2020-09-28T12:16:55Z | |
| dc.date.available | 2020-09-28T12:16:55Z | |
| dc.date.issued | 2019-07-25 | |
| dc.identifier.citation | Ireland. Department of Health, 'Clinical guidance on cannabis for medical use', [other], Department of Health, 2019-07-25 | en |
| dc.description | This Clinical Guidance will form part of the Cannabis for Medical Use Access Programme, once it has been established.
Access to authorised cannabis-based products is limited in Ireland as no cannabis-based authorised medicines are currently marketed here. Where authorised cannabis-based medicines are not available, cannabis-based products that are not authorised as medicines may be used by doctors for patients under their care, based on specific criteria. As there is limited clinical information on the use of cannabis-based products for medical purposes, this guidance aims to provide practical clinical information to healthcare professionals who are prescribing, dispensing and monitoring cannabis-based products.
The Cannabis for Medical Use Access Programme is not required or intended for authorised medicinal products but rather is to facilitate access to cannabis-based products that are not authorised as medicines but are of a standardised quality and meet an acceptable level of quality assurance during their manufacturing process. | en |
| dc.language.iso | en | en |
| dc.publisher | Department of Health | en |
| dc.rights | Y | en |
| dc.subject | Health | en |
| dc.subject | Cannabis | en |
| dc.subject | Medical purposes | en |
| dc.title | Clinical guidance on cannabis for medical use | en |
| dc.type | other | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | Ireland. Department of Health | en |
| dc.publisher.place | IE | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.uri | http://hdl.handle.net/2262/93573 | |
